• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞性甲状腺炎在甲状腺微小乳头状癌中的发病率日益增高。

The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.

机构信息

Department of Clinical and Experimental Medicine, University of Messina, Viale Gazzi, 98125, Messina, Italy.

Department of Human Pathology of Adult and Evolutive Age "Gaetano Barresi"-Section of Pathological Anatomy, University of Messina, Viale Gazzi, 98125, Messina, Italy.

出版信息

Rev Endocr Metab Disord. 2018 Dec;19(4):301-309. doi: 10.1007/s11154-018-9474-z.

DOI:10.1007/s11154-018-9474-z
PMID:30456477
Abstract

Although the incidence of some malignancy has decreased over the recent years, this is not the case of papillary thyroid microcarcinoma (PTMC), whose incidence has increased worldwide. Most PTMC are found incidentally after histological examination of specimens from surgery for benign thyroid disease. Hashimoto's thyroiditis, whose incidence has also increased, coexists in about one in three PTMC patients. Three different mechanisms have been proposed to clarify the association between chronic lymphocytic thyroiditis and PTMC, namely tumor development/growth by: (i) TSH stimulation, (ii) expression of certain proto-oncogenes, (iii) chemokines and other molecules produced by the lymphocytic infiltrate. Whether Hashimoto's thyroiditis protects against lymph node metastasis is debated. Overall, autommune thyroiditis seems to contribute to the favorable prognosis of PTMC. Major limitations of the studies so far performed include: (i) retrospective design, (ii) limited statistical power, (iii) high risk of selection bias, (iv) and predominant Asian ethnicity of patients. Full genetic profiling of both diseases and identification of environmental factors capable to trigger them, as well as well-powered prospective studies on different ethnical groups, may help understand their causal association and why their frequencies are continuing raising.

摘要

尽管近年来某些恶性肿瘤的发病率有所下降,但甲状腺微小乳头状癌(PTMC)的发病率却呈上升趋势,这种情况并非如此。大多数 PTMC 是在因良性甲状腺疾病手术切除标本的组织学检查中偶然发现的。桥本甲状腺炎的发病率也有所上升,约有三分之一的 PTMC 患者同时患有桥本甲状腺炎。目前提出了三种不同的机制来阐明慢性淋巴细胞性甲状腺炎与 PTMC 之间的关联,即:(i)TSH 刺激、(ii)某些原癌基因的表达、(iii)淋巴细胞浸润产生的趋化因子和其他分子。桥本甲状腺炎是否能预防淋巴结转移仍存在争议。总的来说,自身免疫性甲状腺炎似乎有助于改善 PTMC 的预后。迄今为止进行的研究主要存在以下局限性:(i)回顾性设计、(ii)统计能力有限、(iii)选择偏倚风险高、(iv)患者主要为亚洲人。对这两种疾病进行全面的基因分析,并确定能够引发它们的环境因素,以及在不同种族群体中进行大规模的前瞻性研究,可能有助于了解它们的因果关联,以及为什么它们的发病率仍在持续上升。

相似文献

1
The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.慢性淋巴细胞性甲状腺炎在甲状腺微小乳头状癌中的发病率日益增高。
Rev Endocr Metab Disord. 2018 Dec;19(4):301-309. doi: 10.1007/s11154-018-9474-z.
2
The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.并存的桥本甲状腺炎对甲状腺微小乳头状癌淋巴结转移及预后的影响
Tumour Biol. 2016 Jun;37(6):7685-92. doi: 10.1007/s13277-015-4534-4. Epub 2015 Dec 21.
3
Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma.桥本甲状腺炎——乳头状癌的独立危险因素。
Braz J Otorhinolaryngol. 2018 Nov-Dec;84(6):729-735. doi: 10.1016/j.bjorl.2017.08.012. Epub 2017 Sep 14.
4
Is Hashimoto's thyroiditis a prognostic factor for thyroid papillary microcarcinoma?桥本甲状腺炎是甲状腺微小乳头状癌的一个预后因素吗?
Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1910-5.
5
Hashimoto's Thyroiditis is an Important Risk Factor of Papillary Thyroid Microcarcinoma in Younger Adults.桥本甲状腺炎是年轻成年人甲状腺微小乳头状癌的重要危险因素。
Horm Metab Res. 2017 Oct;49(10):732-738. doi: 10.1055/s-0043-117892. Epub 2017 Aug 31.
6
Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.具有免疫球蛋白G4阳性浆细胞的沃辛样甲状腺乳头状癌可能与桥本甲状腺炎相关。
Endocr J. 2018 Feb 26;65(2):175-180. doi: 10.1507/endocrj.EJ17-0319. Epub 2017 Nov 2.
7
Coexistence of Hashimoto's thyroiditis and papillary thyroid carcinoma revisited in thyroidology, an experience from an endemic region: fad or future?桥本甲状腺炎与甲状腺乳头状癌共存的再探讨——来自地方性区域的经验:一时风尚还是未来趋势?
Rev Assoc Med Bras (1992). 2024 May 13;70(4):e20231380. doi: 10.1590/1806-9282.20231380. eCollection 2024.
8
Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.桥本甲状腺炎不影响甲状腺乳头状癌患者的超声、细胞学及组织病理学特征。
Endocr Pathol. 2015 Dec;26(4):356-64. doi: 10.1007/s12022-015-9401-8.
9
Coexistence of papillary carcinoma and Hashimoto's thyroiditis.乳头状癌与桥本甲状腺炎并存。
Acta Clin Croat. 2009 Mar;48(1):9-12.
10
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.甲状腺微小乳头状癌手术的临床病理特征、预后及其与BRAFV600E突变状态和血管生成因子表达的关系
PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.

引用本文的文献

1
A study on the clinical value of prophylactic contralateral central lymph node dissection in patients with cT1-T2N1b unilateral papillary thyroid cancer.cT1-T2N1b期单侧甲状腺乳头状癌患者预防性对侧中央区淋巴结清扫术的临床价值研究
Front Oncol. 2025 Jul 16;15:1629656. doi: 10.3389/fonc.2025.1629656. eCollection 2025.
2
RASGEF1C methylation for the distinguishment and classification of benign and malignant thyroid tumors.用于鉴别和分类甲状腺良恶性肿瘤的RASGEF1C甲基化
Clin Epigenetics. 2025 Jul 14;17(1):124. doi: 10.1186/s13148-025-01931-y.
3
Value of dynamic contrast-enhanced ultrasound in predicting cervical lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.

本文引用的文献

1
Risk factors associated with intrathyroid extension of thyroid microcarcinomas.甲状腺微小癌甲状腺内扩展相关的危险因素。
Langenbecks Arch Surg. 2018 Aug;403(5):615-622. doi: 10.1007/s00423-018-1680-3. Epub 2018 May 17.
2
Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.甲状腺癌:中国东南部浙江省的发病、死亡趋势和临床病理特征。
BMC Cancer. 2018 Mar 15;18(1):291. doi: 10.1186/s12885-018-4081-7.
3
Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
动态对比增强超声在预测合并桥本甲状腺炎的乳头状甲状腺癌患者颈部淋巴结转移中的价值
Gland Surg. 2025 Apr 30;14(4):597-610. doi: 10.21037/gs-2024-510. Epub 2025 Apr 17.
4
A multicenter diagnostic study of thyroid nodule with Hashimoto's thyroiditis enabled by Hashimoto's thyroiditis nodule-artificial intelligence model.基于桥本甲状腺炎结节人工智能模型的甲状腺结节合并桥本甲状腺炎多中心诊断研究
Eur Radiol. 2025 Feb 13. doi: 10.1007/s00330-025-11422-6.
5
Optimizing thyroid AUS nodules malignancy prediction: a comprehensive study of logistic regression and machine learning models.优化甲状腺 AUS 结节恶性预测:逻辑回归和机器学习模型的综合研究。
Front Endocrinol (Lausanne). 2024 Nov 6;15:1366687. doi: 10.3389/fendo.2024.1366687. eCollection 2024.
6
Predicting lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis using regression and network analysis.利用回归和网络分析预测桥本甲状腺炎合并甲状腺乳头状癌的淋巴结转移。
Sci Rep. 2024 Nov 11;14(1):27585. doi: 10.1038/s41598-024-78179-8.
7
Association of thyroid autoantibodies with aggressive characteristics of papillary thyroid cancer: a case-control study.甲状腺自身抗体与甲状腺乳头状癌侵袭性特征的关系:一项病例对照研究。
World J Surg Oncol. 2024 Aug 27;22(1):224. doi: 10.1186/s12957-024-03501-7.
8
Thyrotropin (TSH) and thyroid autoimmunity are predictive factors for the incidental discovery of papillary thyroid microcarcinoma during thyroidectomy.促甲状腺激素(TSH)和甲状腺自身免疫是甲状腺切除术中意外发现甲状腺微小乳头状癌的预测因素。
Endocrine. 2024 Nov;86(2):723-731. doi: 10.1007/s12020-024-03907-z. Epub 2024 Jun 19.
9
Detection of malignant lesions in cytologically indeterminate thyroid nodules using a dual-layer spectral detector CT-clinical nomogram.使用双层光谱探测器CT临床列线图检测甲状腺细针穿刺结果不确定的结节中的恶性病变
Front Oncol. 2024 May 28;14:1357419. doi: 10.3389/fonc.2024.1357419. eCollection 2024.
10
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.
术前促甲状腺激素与甲状腺乳头状癌临床病理及侵袭性特征的关系。
Endocrine. 2018 Mar;59(3):565-572. doi: 10.1007/s12020-018-1523-6. Epub 2018 Jan 27.
4
Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.甲状腺乳头状微小癌中央区淋巴结转移的预测。
Turk J Med Sci. 2017 Dec 19;47(6):1723-1727. doi: 10.3906/sag-1702-99.
5
One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007-2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging.一组甲状腺乳头状癌档案系列(2007年至2015年)中有三分之一同时存在慢性淋巴细胞性甲状腺炎,这与更有利的肿瘤-淋巴结-转移分期相关。
Front Endocrinol (Lausanne). 2017 Dec 1;8:337. doi: 10.3389/fendo.2017.00337. eCollection 2017.
6
Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.血清促甲状腺激素水平作为甲状腺结节恶性肿瘤预测指标的前瞻性研究。
PLoS One. 2017 Nov 16;12(11):e0188123. doi: 10.1371/journal.pone.0188123. eCollection 2017.
7
Associations between Systemic Sclerosis and Thyroid Diseases.系统性硬化症与甲状腺疾病之间的关联。
Front Endocrinol (Lausanne). 2017 Oct 3;8:266. doi: 10.3389/fendo.2017.00266. eCollection 2017.
8
Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.预测甲状腺微小乳头状癌(CN0)中央区淋巴结转移的风险因素:273 例切除标本的研究。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3801-3807.
9
Hashimoto's Thyroiditis is an Important Risk Factor of Papillary Thyroid Microcarcinoma in Younger Adults.桥本甲状腺炎是年轻成年人甲状腺微小乳头状癌的重要危险因素。
Horm Metab Res. 2017 Oct;49(10):732-738. doi: 10.1055/s-0043-117892. Epub 2017 Aug 31.
10
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia.丙型肝炎病毒感染患者伴/不伴混合性冷球蛋白血症时的甲状腺受累情况
Front Endocrinol (Lausanne). 2017 Jul 7;8:159. doi: 10.3389/fendo.2017.00159. eCollection 2017.